A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects

Clinical trial NCT07065058 · COMPLETED

Trial details

NCT number: NCT07065058
Sponsor: Vincentage Pharma Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Obesity &Amp; Overweight

Start date: 2025-07-01
Primary completion: 2025-07-11
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.